Mylan to restart production of possible covid 19 drug at it's Morgantown plant
MORGANTOWN — Mylan’s Morgantown plan is restarting production of an anti-malaria medication that is under study as a potential treatment for the COVID-19 virus.
The anon who posted it asked for it to be removed, they recognized the problem after they posted and it was notabled, guess the baker missed the request.
yes, the mouse got loose and bit the reply button..kek
Mylan to restart production of possible covid 19 drug at it's Morgantown plant
MORGANTOWN — Mylan’s Morgantown plan is restarting production of an anti-malaria medication that is under study as a potential treatment for the COVID-19 virus. The drug is hydroxychloroquine sulfate; the tablets are approved by the U.S. Food and Drug Administration for the treatment of malaria, lupus erythematosus and rheumatoid arthritis. President Trump on Thursday touted its cousin, chloroquine, as a potential treatment and mistakenly said it has been FDA approved for COVID-19.
Mylan clarified, “Although the product is not currently approved for use in the treatment of COVID-19, it is listed by the World Health Organization as a drug under investigation for efficacy against the coronavirus.” The drug had been in short supply earlier in March, according to news reports, but Mylan and another generic drug firm, Israel-based Teva, are both ramping up production. Mylan said in a press release, “The company continues to focus its efforts on protecting our employees, producing critically needed medications, and turning our scientific and operational expertise towards identifying additional ways we may be able to assist in the massive prevention, diagnosis and treatment efforts needed to counter the spread of COVID-19.” The restart of hydroxychloroquine sulfate in Morgantown in order to meet potential increased demand is part of that effort, Mylan said. In the coming weeks, Mylan also plans to begin production outside the U.S. “We look forward to working with governments and health authorities globally to ensure patient access to this medicine as and where needed,” Mylan said. Mylan said it expects to be in a position to begin supplying the tablets by mid-April. “With the active pharmaceutical ingredient that we currently have available, will be able to ramp up manufacturing to provide 50 million tablets to potentially treat a total of more than 1.5 million patients. The potential use of this medicine for COVID-19 related treatment is pending additional FDA and other regulatory body guidance.”
Teva announced that it is donating more than 6 million doses of the tablets through wholesalers to hospitals across the U.S. “to meet the urgent demand for the medicine as an investigational target to treat COVID-19.” Teva Executive Vice President, North America Commercial Brendan O’Grady said, “We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost. Immediately upon learning of the potential benefit of hyroxychloroquine, Teva began to assess supply and to urgently acquire additional ingredients to make more product while arranging for all of what we had to be distributed immediately.” Teva said it plans ship the 6 million tablets through wholesalers to hospitals by March 31, and more than 10 million within a month. It is reviewing supply of both hydroxychloroquine and chloroquine globally to determine whether there are additional supply and access opportunities for patients.
The Dominion Post asked Mylan if it planned to also donate tablets, and how the restarted production will affect the Morgantown plant; Mylan acknowledged the questions but was unable to supply the answers by deadline.
https://www.dominionpost.com/2020/03/20/mylan-to-restart-production-of-possible-covid-19-drug-at-its-morgantown-plant/
Democrats block advancement of critical economic relief package
Senate Democrats Sunday blocked a critical economic relief package worth more than $2 trillion, stalling plans to pass the bill by Monday and send it to the House. Lawmakers and the Trump administration hoped to send a positive message to unstable stock markets and to those worried about the damage to the economy and the job losses caused by the spread of the virus. The measure includes sending direct cash payments that would average about $3,000 per family and expanding unemployment insurance, as well as $350 billion in aid to struggling small businesses. It also provides $500 billion in loans to industries hurt by the economic slowdown.
But Democrats are holding out for big changes to the bill, which they argue creates a "slush fund" for big industries and lacks sufficient protections for workers. They voted against a procedural step to start debate on the bill, which Senate Majority Leader Mitch McConnell hoped to pass by Monday. McConnell, visibly angry on the Senate floor, entered a motion to reconsider the measure and said he'd bring it up again for a vote by Monday. "We'll have this…vote again at some point of my choosing and hopefully some adults will show up on the other side of the room and understand the gravity of the situation and the need to act before the markets go down further and the American people become even more depressed about our lack of ability to come together under the most extraordinary of circumstances," he said.
The Senate bill is the product of a day of bipartisan talks and includes many of the provisions sought by Democrats. House Speaker Nancy Pelosi, a California Democrat, said Democrats are now writing their own bill in the House. That measure is likely to include protections for workers, unemployment insurance expansion beyond what is in the Senate bill, and partial student loan forgiveness. Democrats also seek additional “restraints” on how the Treasury can use liquidity to help industries hurt by the economic slowdown. On Fox News Sunday, Treasury Secretary Steven Mnuchin said the federal government would be able to leverage $4 trillion to help businesses for up to 120 days. They also seek hundreds of billions of dollars in aid to states to help them deal with medical costs associated with the coronavirus. The Senate bill includes $110 billion, but Democrats say it's not enough to address the shortages of protective gear and equipment for healthcare workers. "It falls short of what medical providers need," Sen. Joe Manchin, a key centrist Democrat from West Virginia, said ahead of the vote.
Senate Minority Leader Chuck Schumer, a New York Democrat, accused Republicans of drafting a partisan measure and said he is working with Treasury Secretary Steve Mnuchin to change the legislation and achieve a deal. "We're close than we've ever been at any time over the past 48 hours to an agreement," Schumer said. "But there are still too many problems in the propsed legislation. Can we overcome the remaining disagreements in the next 24 hours? Yes we can. And we should. The nation demands it."
https://www.washingtonexaminer.com/news/congress/democrats-block-advancement-of-critical-economic-relief-package